Caribou Biosciences's market cap is currently $128.58M. The company's EPS TTM is $-1.652; its P/E ratio is ―; Caribou Biosciences is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 34.48M	$ 13.85M	$ 9.60M	$ 12.36M	$ 5.79M
Gross Profit	$ -77.60M	$ 10.21M	$ 8.61M	$ -22.06M	$ -17.85M
Operating Income	$ -116.06M	$ -106.40M	$ -66.98M	$ -36.12M	$ -34.30M
EBITDA	$ -112.53M	$ -104.78M	$ -66.00M	$ -35.21M	$ -30.21M
Net Income	$ -102.07M	$ -99.42M	$ -66.92M	$ -34.31M	$ -23.43M
Balance Sheet
Cash & Short-Term Investments	$ 328.83M	$ 317.04M	$ 413.51M	$ 15.95M	$ 49.47M
Total Assets	$ 432.21M	$ 373.76M	$ 442.36M	$ 36.05M	$ 61.93M
Total Debt	$ 27.11M	$ 27.75M	$ 259.00K	$ 1.58M	$ 532.00K
Net Debt	$ -24.05M	$ -30.59M	$ -240.16M	$ -14.38M	$ -40.54M
Total Liabilities	$ 63.81M	$ 72.89M	$ 54.53M	$ 59.48M	$ 54.47M
Stockholders' Equity	$ 368.40M	$ 300.87M	$ 387.82M	$ -23.44M	$ 7.46M
Cash Flow
Free Cash Flow	$ -104.90M	$ -98.02M	$ -35.64M	$ -34.53M	$ -32.89M
Operating Cash Flow	$ -93.29M	$ -90.97M	$ -32.52M	$ -33.22M	$ -32.01M
Investing Cash Flow	$ -68.18M	$ -93.25M	$ -176.40M	$ 6.36M	$ 27.23M
Financing Cash Flow	$ 154.30M	$ 2.13M	$ 433.43M	$ 1.74M	$ 172.00K

Currency in USD

Caribou Biosciences Earnings and Revenue History

Income Statement >

Caribou Biosciences Debt to Assets

Balance Sheet >

Caribou Biosciences Cash Flow

Cash Flow >

Caribou Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing